z-logo
open-access-imgOpen Access
Phenotype and Genotype Characteristics of Staphylococcus aureus Resistant to Methicillin/Oxacillin Carrying Gene mecC in the Czech Republic from 2002 to 2017
Author(s) -
Lucia Mališová,
Vladislav Jakubů,
Martin Musílek,
Jana Kekláková,
Helena Žemličková
Publication year - 2020
Publication title -
microbial drug resistance
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.889
H-Index - 70
eISSN - 1931-8448
pISSN - 1076-6294
DOI - 10.1089/mdr.2019.0319
Subject(s) - multilocus sequence typing , microbiology and biotechnology , staphylococcus aureus , biology , erythromycin , genotype , methicillin resistant staphylococcus aureus , sccmec , typing , clindamycin , trimethoprim , tetracycline , antibiotics , gene , genetics , bacteria
The aim of this study was to detect and characterize isolates of methicillin-/oxacillin-resistant Staphylococcus aureus (MRSA) carrying gene mecC (MRSA/ mecC ) and occurring in the Czech Republic within the period from 2002 to 2017. Altogether, 18 from 3,472 isolates of MRSA were mecC positive (0.52%). The first detection of MRSA/ mecC in the Czech Republic is dated to 2004. MRSA/ mecC isolates were susceptible to almost all tested antibiotics with few exceptions. Resistances to erythromycin ( n  = 2), clindamycin ( n  = 1), trimethoprim-sulfamethoxazole ( n  = 1), and rifampicin ( n  = 1) were found in the collection. Multilocus sequence typing and spa typing revealed a genetic heterogeneity of MRSA/ mecC strains: three CCs (130, 425, and 2361), five STs (1245, 130, 2361, 425, and a new ST5480), and eight spa types (t843, t978, t1048, t1535, t1736, t6104, t8842, and t17153), which were detected in the study, with the highest prevalence of CC130/t843 lineage ( n  = 8, 44%). Except for two strains, none from 18 examined isolates harbored genes encoding any of S. aureus toxins: enterotoxins a-u, exfoliative toxins A, B, and D, toxic shock syndrome toxin-1, and the Panton-Valentine leukocidin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here